RET-Positive Lung Cancer Research: How Tissue Donation Helps
RET-positive lung cancer is rare, and researchers need better lab models to study it. Learn how donating tumor tissue can help create cell lines and advance targeted treatments.
RET-positive lung cancer is a rare type of cancer driven by a change in a gene called RET, which stands for “rearranged during transfection.” This gene helps control how cells grow and divide. When it fuses with another gene or mutates, it can cause cancer to grow and spread, especially in certain lung and thyroid cancers. Because RET changes are so rare, researchers don’t have enough lab models called cancer cell lines. That makes it harder to study how the cancer behaves and becomes resistant to treatment.
One powerful way patients can help is by donating tumor tissue during a biopsy or surgery. That tissue can be used to grow RET-positive cancer cells in the lab, giving scientists tools to test new treatments and develop better, more personalized options. Thanks to the generosity of several RET patients, four new cancer cell lines are now being developed. If you’re a patient, talk to your care team about donating. Your gift could move research forward and help bring better treatments to others living with RET-driven cancer. (Source: The Happy Lungs Project)
Read the complete article here >
Resources for Living With Stage 4 Cancer
Learn more about topics like RET-positive lung cancer research. Become a member of our community to gain access to trusted resources, as well as online support and education from Dr. Sharon May, Ph.D., LMFT.
